These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20054110)

  • 1. Tehranolide could shift the immune response towards Th1 and modulate the intra-tumor infiltrated T regulatory cells.
    Noori S; Taghikhani M; Hassan ZM; Allameh A; Mostafaei A
    Iran J Immunol; 2009 Dec; 6(4):216-24. PubMed ID: 20054110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tehranolide molecule modulates the immune response, reduce regulatory T cell and inhibits tumor growth in vivo.
    Noori S; Taghikhani M; Hassan ZM; Allameha A; Mostafaei A
    Mol Immunol; 2010 Apr; 47(7-8):1579-84. PubMed ID: 20138670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone can improve the anti-tumor immunity by reducing the CD4+CD25+Foxp3+ regulatory T cells in BALB/c mice.
    Molla Hassan AT; Hassan ZM; Moazzeni SM; Mostafaie A; Shahabi S; Ebtekar M; Hashemi SM
    Int Immunopharmacol; 2009 Nov; 9(12):1381-6. PubMed ID: 19706340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclareol modulates the Treg intra-tumoral infiltrated cell and inhibits tumor growth in vivo.
    Noori S; Hassan ZM; Mohammadi M; Habibi Z; Sohrabi N; Bayanolhagh S
    Cell Immunol; 2010; 263(2):148-53. PubMed ID: 20409537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of Artemisia princeps in antigen-stimulated T cells and regulatory T cells.
    Chang SH; Jung EJ; Park YH; Lim DG; Ko NY; Choi WS; Her E; Kim SH; Choi KD; Bae JH; Kim SH; Kang CD; Han DJ; Kim SC
    J Pharm Pharmacol; 2009 Aug; 61(8):1043-50. PubMed ID: 19703348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obaculactone suppresses Th1 effector cell function through down-regulation of T-bet and prolongs skin graft survival in mice.
    Gong F; Shen Y; Zhang Q; Sun Y; Tang J; Tao F; Xu Q
    Biochem Pharmacol; 2010 Jul; 80(2):218-25. PubMed ID: 20361943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
    J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The enhancing effect of "Xuebijing injection" on lipopolysaccharide-induced apoptosis of regulatory T cells and mediation of polarization of helper T cells].
    Dai XG; Yao YM; Ai YH; Yu Y
    Zhonghua Shao Shang Za Zhi; 2009 Apr; 25(2):106-10. PubMed ID: 19799034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suppressive effect of induced CD4+CD25+ regulatory T cells from mice infected with Schistosoma japonicum].
    Tan MJ; Zhang YC; Wang Y; Hu W; Liang YJ; Zhang L
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Jun; 26(3):166-9, 173. PubMed ID: 19160959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
    Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
    Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
    Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclareol reduces CD4+ CD25+ FoxP3+ Treg cells in a breast cancer model in vivo.
    Noori S; Hassan ZM; Salehian O
    Iran J Immunol; 2013 Mar; 10(1):10-21. PubMed ID: 23502334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-LFA-1 antibody postpones T-cell receptor triggering while preserving generation of regulatory T cells in T-cell receptor anti-HY transgenic mice.
    Go S; Fleischmann A; Lantz O; Cretolle C; Brousse N; Cerf-Bensussan N; Sarnacki S
    Transplantation; 2006 Jul; 82(1):119-26. PubMed ID: 16861951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor and immunomodulatory effects of salvigenin on tumor bearing mice.
    Noori S; Hassan ZM; Yaghmaei B; Dolatkhah M
    Cell Immunol; 2013; 286(1-2):16-21. PubMed ID: 24270218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
    Viehl CT; Moore TT; Liyanage UK; Frey DM; Ehlers JP; Eberlein TJ; Goedegebuure PS; Linehan DC
    Ann Surg Oncol; 2006 Sep; 13(9):1252-8. PubMed ID: 16952047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
    DiIulio NA; Xu H; Fairchild RL
    Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.